Med Page Today
APRIL 22, 2024
(MedPage Today) -- Through my work as a neuroscientist who designs neural implants to monitor the injured brain after severe traumatic brain injuries, stroke, and brain cancers, it has become very clear to me that my field needs to communicate.
American Heart News - Heart News
APRIL 22, 2024
DALLAS, April 22, 2024 — More Black and Hispanic people in the U.S. feel confident performing Cardiopulmonary Resuscitation (CPR). A 2023 American Heart Association survey found that 44% of Black Americans now feel confident in performing.
Science Daily - Heart Disease
APRIL 22, 2024
Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, dementia and stroke. It constitutes a significant burden to healthcare systems, making its early detection and treatment a major goal. Researchers have recently developed a deep-learning model capable of predicting the transition from a normal cardiac rhythm to atrial fibrillation.
Dr. Smith's ECG Blog
APRIL 22, 2024
A 50-something male with hypertension and 20- to 40-year smoking history presented with 1 week of stuttering chest pain that is worse with exertion, which takes many minutes to resolve after resting and never occurs at rest. It is a ssociated with mild dyspnea on exertion. At times the pain does go to his left neck. It was present on arrival at triage but then resolved before bed placement in the ED.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Med Page Today
APRIL 22, 2024
(MedPage Today) -- Continued use of a glucagon-like peptide 1 (GLP-1) receptor agonist leading up to surgery may not increase the risk for regurgitation and pulmonary aspiration during operations after all, an analysis of insurance claims data.
HCPLive
APRIL 22, 2024
Nahas reviews key highlights from her session at ACP, emphasizing the importance of reviewing patient history and considering what other factors may be causing headaches.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
HCPLive
APRIL 22, 2024
Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.
DAIC
APRIL 22, 2024
milla1cf Mon, 04/22/2024 - 15:01 April 22, 2024 — Corvia Medical, Inc , a company dedicated to transforming the treatment of heart failure , welcomes the recent release of V-Wave's RELIEVE-HF trial data supporting the evidence base around atrial shunt therapy, which is currently under study in the global RESPONDER-HF trial of the Corvia Atrial Shunt.
American College of Cardiology
APRIL 22, 2024
The goal of the DICTATE-AHF trial was to determine the efficacy and safety of adding the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin to intravenous (IV) loop diuretic therapy in patients hospitalized with acute decompensated heart failure (ADHF).
HCPLive
APRIL 22, 2024
Cerceo, Peden, and Ziska joined HCPLive to speak on the imminent threat posed by climate change, highlighting the impact especially on individuals with allergic disease.
American College of Cardiology
APRIL 22, 2024
What is the 5-year incidence of valve reintervention after self-expanding CoreValve/Evolut transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR)?
HCPLive
APRIL 22, 2024
Post-treatment with risankizumab, the cDAPSA score, PGA score, and PASI score substantially decreased among a cohort of patients with psoriatic arthritis.
American College of Cardiology
APRIL 22, 2024
The following are key points to remember from an American Heart Association (AHA) scientific statement on the diagnosis and management of cardiac sarcoidosis (CS).
HCPLive
APRIL 22, 2024
A poll found people were more likely to use alternate health care sites if they were women, aged 50 – 64 over 65 – 80 years, and had a household income of < $60,000.
Med Page Today
APRIL 22, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Marsha Certain, MD, an interventional cardiologist from Georgia, was killed late last week, at age 69, in an apparent murder-suicide, according to authorities.
American College of Cardiology
APRIL 22, 2024
Is there a difference in clinical performance between different bileaflet mechanical aortic valve prostheses?
Science Daily - Heart Disease
APRIL 22, 2024
Atrial fibrillation (Afib), a common type of arrhythmia that is on the rise in people under the age of 65, is more dangerous in this increasingly younger population than previously thought, according to new research.
Nature Reviews - Cardiology
APRIL 22, 2024
Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01032-y According to data from the IMPROVE-HCM trial, ninerafaxstat is well tolerated by patients with symptomatic non-obstructive hypertrophic cardiomyopathy and improves exercise performance among those who are most symptomatically limited.
Journal of Cardiothoracic Surgery
APRIL 22, 2024
The aim of this study was to assess the ability of radiologic factors such as mean computed tomography (mCT) value, consolidation/tumor ratio (C/T ratio), solid tumor size, and the maximum standardized uptake.
Society of Thoracic Surgeons - Congenital
APRIL 22, 2024
Resource Multi-Valve Surgery Risk Calculator kchalko Mon, 04/22/2024 - 14:57 The expanding use of transcatheter valve technologies has changed the landscape in the treatment of valvular disease. Valve surgery is rapidly shifting to more complex scenarios that involve multiple valve interventions and concomitant procedures. STS leveraged contemporary national data from the STS Adult Cardiac Surgery Database between July 2017 and December 2023 to analyze outcomes of 32,938 patients that underwent
Journal of Cardiothoracic Surgery
APRIL 22, 2024
It is essential to find reliable biomarkers for early diagnosis and prognosis of acute heart failure (AHF) for its mitigation. Currently, increasing attention is paid to the role of microRNAs (miRNAs/miRs) as.
Nature Reviews - Cardiology
APRIL 22, 2024
Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01034-w Three randomized clinical trials presented at ACC.24 demonstrate that olezarsen and plozasiran, RNA-based therapies that target APOC3, can robustly reduce plasma triglyceride levels in patients with moderate to severe hypertriglyceridaemia.
Journal of Cardiothoracic Surgery
APRIL 22, 2024
The relationship between venous congestion in cardiopulmonary bypass (CPB) and acute kidney injury (AKI) in cardiac surgery has not utterly substantiated. This study aimed at investigate the relationship betwe.
Nature Reviews - Cardiology
APRIL 22, 2024
Nature Reviews Cardiology, Published online: 23 April 2024; doi:10.1038/s41569-024-01035-9 Data from the DanGer Shock trial demonstrate that implantation of a microaxial flow pump in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock increases the survival rate compared with standard care alone.
HCPLive
APRIL 22, 2024
The expert panel addresses the common assumption of medication non-adherence in patients with resistant diabetes, provides strategies to differentiate non-adherence from underlying comorbidities contributing to resistance, and discusses the challenges of patients who are post-metabolic surgery, yet experience weight gain and symptom recurrence.
Frontiers in Cardiovascular Medicine
APRIL 22, 2024
Right aortic arch with isolation of left brachiocephalic artery is a rare congenital aortic arch anomaly. Herein, we reported a case of this rare anomaly with ventricular septal defect in a 9-month-old infant. We successfully reconstructed the islolated left brachiocephalic artery and repaired the ventricular septal defect in one stage.
HCPLive
APRIL 22, 2024
The national registry-based analysis in Denmark may inform the clinical value of medication adherence in the first years of glaucoma treatment.
Cardiology Update
APRIL 22, 2024
In a prospective, multicentre, parallel, randomised clinical trial titled ARREST, researchers aimed to evaluate the effectiveness of expedited transfer to a cardiac arrest center compared to standard care following out-of-hospital cardiac arrest. The ARREST study is the first randomized trial of its kind. Conducted in the UK, the study enrolled 862 patients aged 18 or older who experienced return of spontaneous circulation after cardiac arrest without ST elevation.
HCPLive
APRIL 22, 2024
Hanford Yau, MD, Ralph DeFronzo, MD, Pam Kushner, MD, Honey East, MD, and Christopher Lucci, MD, explore resistant diabetes, share their clinical experience regarding the frequency of this condition, and highlight the role of continuous glucose monitoring in identifying patients who may be resistant, as indicated by prolonged periods of blood glucose levels outside the target range.
All About Cardiovascular System and Disorders
APRIL 22, 2024
Heart disease can occur with both increased function of the thyroid gland and decreased function of the thyroid gland. When thyroid function is increased, heart rate increases and the work load of the heart increases. In severe cases heart failure may occur. A peculiarity of heart failure associated with increased thyroid function is that it is a high output failure unlike the usual heart failure in which the pumping function of the heart is reduced, and low output failure occurs.
HCPLive
APRIL 22, 2024
Announced on April 18, the approval is based on the VISIBLE 2 trial and comes less than 7 months after the approval of SC vedolizumab in ulcerative colitis.
HeartRhythm
APRIL 22, 2024
Single- or dual-chamber devices may be implanted in patients requiring a permanent pacemaker (PPM) with a preserved left ventricular ejection fraction and without permanent atrial fibrillation (AF). Although studies have failed to show a mortality benefit of dual- over single-chamber pacing, dual-chamber pacing is associated with lower risks of AF and pacemaker syndrome.
HCPLive
APRIL 22, 2024
Branch discusses key takeaways from his session at ACP and guideline recommendations for primary and secondary prevention of cardiovascular disease.
HeartRhythm
APRIL 22, 2024
Implantable cardiac defibrillator (ICD) implantation can protect against sudden cardiac death (SCD) after a myocardial infarction. However, improved risk stratification for device requirement is still needed.
HCPLive
APRIL 22, 2024
Thorndike discussed highlights from her ACP 2024 talk titled ‘Annals Beyond the Guidelines: How Would You Treat this Patient with Obesity?
HeartRhythm
APRIL 22, 2024
Mitral valve prolapse (MVP) is a common condition (prevalence 2-3 %)1, with a good prognosis. However, some MVP patients experience severe ventricular arrhythmias (VA). Identifying patients at risk is challenging and evidence is sparse. The predictive role of exercise testing in MVP has not been investigated. We aimed to explore whether exercise ECG could predict subsequent severe VA in MVP patients.
Expert insights. Personalized for you.
140 
Let's personalize your content